Article: Biochemistry of protein tyrosine nitration in cardiovascular pathology.
2007 Volume 75, Issue 2, Page(s) 291–302
Abstract: Several pathologies of the cardiovascular system are associated with an augmented production of nitric oxide and/or superoxide-derived oxidants and/or alteration in the antioxidant detoxification pathways that lead to nitroxidative stress. One important ... ...
Abstract | Several pathologies of the cardiovascular system are associated with an augmented production of nitric oxide and/or superoxide-derived oxidants and/or alteration in the antioxidant detoxification pathways that lead to nitroxidative stress. One important consequence of these reactive intermediates at the biochemical level is the nitration of protein tyrosines, which is performed through either of two of the relevant nitration pathways that operate in vivo, namely peroxynitrite and heme peroxidase-dependent nitration. Proteins nitrated at tyrosine residues have been detected in several compartments of the cardiovascular system. In this review a selection of nitrated proteins in plasma (fibrinogen, plasmin, Apo-1), vessel wall (Apo-B, cyclooxygenase, prostaglandin synthase, Mn-superoxide dismutase) and myocardium (myofibrillar creatine kinase, alpha-actinin, sarcoplasmic reticulum Ca(2+) ATPase) are analyzed in the context of cardiovascular disease. Nitration of tyrosine can affect protein function, which could directly link nitroxidative stress to the molecular alterations found in disease. While some proteins are inactivated by nitration (e.g. Mn-SOD) others undergo a gain-of-function (e.g. fibrinogen) that can have an ample impact on the pathophysiology of the cardiovascular system. Nitrotyrosine is also emerging as a novel independent marker of cardiovascular disease. Pharmacological strategies directed towards inhibiting protein nitration will assist to shed light on the relevance of this post-translational modification to human cardiovascular pathology. |
---|---|
MeSH term(s) | Animals ; Cardiovascular Diseases/metabolism ; Cardiovascular System/metabolism ; Fibrinogen/metabolism ; Humans ; Nitric Oxide/metabolism ; Nitrosation ; Signal Transduction/physiology ; Superoxide Dismutase/metabolism ; Tyrosine/analogs & derivatives ; Tyrosine/metabolism |
Chemical Substances | Nitric Oxide (31C4KY9ESH) ; 3-nitrotyrosine (3604-79-3) ; Tyrosine (42HK56048U) ; Fibrinogen (9001-32-5) ; Superoxide Dismutase (EC 1.15.1.1) |
Language | English |
Publishing date | 2007-07-15 |
Publishing country | England |
Document type | Journal Article ; Research Support, Non-U.S. Gov't ; Review |
ZDB-ID | 80340-6 |
ISSN | 1755-3245 ; 0008-6363 |
ISSN (online) | 1755-3245 |
ISSN | 0008-6363 |
DOI | 10.1016/j.cardiores.2007.04.024 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 565: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.